Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0129 Transporter Info | ||||
Gene Name | SLC1A1 | ||||
Transporter Name | Excitatory amino acid transporter 3 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
CEBPB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC1A1 gene | [1] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein beta | Transcription Factor Info | ||||
Tissue |
Bone | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein beta (CEBPB) can directly bind to the SLC1A1 gene, which in turn affects the expression or function of the drug transporter Excitatory amino acid transporter 3. | |||||
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
EPAS1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC1A1 gene in hepatocellular carcinoma condition | [2] | ||||
TF Protein Name |
Endothelial PAS domain-containing protein 1 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Glutamate | |||||
Studied Phenotype |
Hepatocellular carcinoma [ICD11: 2C12.02] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human childhood hepatocellular carcinoma cells (Hep3B) | |||||
Detailed Description |
Endothelial PAS domain-containing protein 1 (EPAS1) has been reported to activate the transcription of SLC1A1 gene in hepatocellular carcinoma condition, which leads to an increased expression of the drug transporter Excitatory amino acid transporter 3. | |||||
HIF1A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC1A1 gene in hepatocellular carcinoma condition | [2] | ||||
TF Protein Name |
Hypoxia-inducible factor 1-alpha | Transcription Factor Info | ||||
Affected Drug/Substrate |
Glutamate | |||||
Studied Phenotype |
Hepatocellular carcinoma [ICD11: 2C12.02] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human childhood hepatocellular carcinoma cells (Hep3B) | |||||
Detailed Description |
Hypoxia-inducible factor 1-alpha (HIF1A) has been reported to activate the transcription of SLC1A1 gene in hepatocellular carcinoma condition, which leads to an increased expression of the drug transporter Excitatory amino acid transporter 3. | |||||
Class1.3: Basic helix-span-helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
TFAP2C |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC1A1 gene | [3] | ||||
TF Protein Name |
Transcription factor AP-2 gamma | Transcription Factor Info | ||||
Tissue |
Breast; Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor AP-2 gamma (TFAP2C) can directly bind to the SLC1A1 gene, which in turn affects the expression or function of the drug transporter Excitatory amino acid transporter 3. | |||||
Class2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
AR |
Click to Show/Hide to Show 3 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC1A1 gene in prostate cancer condition | [4] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Androgen receptor (AR) has been reported to bind to the transcription of SLC1A1 gene in prostate cancer condition, which leads to an affected expression of the drug transporter Excitatory amino acid transporter 3. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC1A1 gene | [5] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Androgen receptor (AR) has been reported to bind to the transcription of SLC1A1 gene in . condition, which leads to a affected expression of the drug transporter Excitatory amino acid transporter 3. | |||||
Transcriptional Phenomenon3 |
Binding to SLC1A1 gene in prostate cancer condition | [6] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Androgen receptor (AR) has been reported to bind to the transcription of SLC1A1 gene in prostate cancer condition, which leads to an affected expression of the drug transporter Excitatory amino acid transporter 3. | |||||
NR3C1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC1A1 gene in ER(-) breast cancer condition | [7] | ||||
TF Protein Name |
Glucocorticoid receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Glucocorticoid receptor (NR3C1) has been reported to activate the transcription of SLC1A1 gene in ER(-) breast cancer condition, which leads to an increased expression of the drug transporter Excitatory amino acid transporter 3. | |||||
Class2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GLIS1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC1A1 gene | [1] | ||||
TF Protein Name |
Zinc finger protein GLIS1 | Transcription Factor Info | ||||
Tissue |
Blood; Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger protein GLIS1 (GLIS1) can directly bind to the SLC1A1 gene, which in turn affects the expression or function of the drug transporter Excitatory amino acid transporter 3. | |||||
Class3.1: Homeo domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
HNF1B |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC1A1 gene in renal cysts condition | [8] | ||||
TF Protein Name |
Hepatocyte nuclear factor 1-beta | Transcription Factor Info | ||||
Studied Phenotype |
Renal cysts [ICD11: GB80] | |||||
Tissue |
Kidney | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Zebrafish TgPT::EGFP) | |||||
Detailed Description |
Hepatocyte nuclear factor 1-beta (HNF1B) has been reported to activate the transcription of SLC1A1 gene in renal cysts condition, which leads to an increased expression of the drug transporter Excitatory amino acid transporter 3. | |||||
NANOG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC1A1 gene in health condition | [9] | ||||
TF Protein Name |
Homeobox protein NANOG | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Homeobox protein NANOG (NANOG) has been reported to bind to the transcription of SLC1A1 gene in health condition, which leads to an affected expression of the drug transporter Excitatory amino acid transporter 3. | |||||
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
FOXA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC1A1 gene | [10] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) can directly bind to the SLC1A1 gene, which in turn affects the expression or function of the drug transporter Excitatory amino acid transporter 3. | |||||
FOXO3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC1A1 gene in tumorigenesis condition | [11] | ||||
TF Protein Name |
Forkhead box protein O3 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Forkhead box protein O3 (FOXO3) has been reported to activate the transcription of SLC1A1 gene in tumorigenesis condition, which leads to an increased expression of the drug transporter Excitatory amino acid transporter 3. | |||||
RFX1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC1A1 gene in brain neuroblastoma condition | [12] | ||||
TF Protein Name |
MHC class II regulatory factor RFX1 | Transcription Factor Info | ||||
Studied Phenotype |
Brain neuroblastoma [ICD11: 2A00.11] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human neuroblastoma cells (SH-SY5Y) | |||||
Detailed Description |
MHC class II regulatory factor RFX1 (RFX1) has been reported to activate the transcription of SLC1A1 gene in brain neuroblastoma condition, which leads to an enhanced function of the drug transporter Excitatory amino acid transporter 3. | |||||
Class3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
ERG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC1A1 gene | [13] | ||||
TF Protein Name |
Transcriptional regulator ERG | Transcription Factor Info | ||||
Tissue |
Aorta | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional regulator ERG (ERG) can directly bind to the SLC1A1 gene, which in turn affects the expression or function of the drug transporter Excitatory amino acid transporter 3. | |||||
SPI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC1A1 gene in acute promyelocytic leukemia condition | [14] | ||||
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor PU.1 (SPI1) has been reported to bind to the transcription of SLC1A1 gene in acute promyelocytic leukemia condition, which leads to an affected expression of the drug transporter Excitatory amino acid transporter 3. | |||||
Class4.1: High-mobility group domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SOX2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC1A1 gene in colorectal cancer condition | [15] | ||||
TF Protein Name |
Transcription factor SOX-2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor SOX-2 (SOX2) has been reported to activate the transcription of SLC1A1 gene in colorectal cancer condition, which leads to an increased expression of the drug transporter Excitatory amino acid transporter 3. | |||||
Class6.1: Rel homology region factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
EBF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC1A1 gene | [3] | ||||
TF Protein Name |
Transcription factor COE1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor COE1 (EBF1) can directly bind to the SLC1A1 gene, which in turn affects the expression or function of the drug transporter Excitatory amino acid transporter 3. | |||||
Class6.4: Runt domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
RUNX2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC1A1 gene in prostate cancer condition | [16] | ||||
TF Protein Name |
Runt-related transcription factor 2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Runt-related transcription factor 2 (RUNX2) has been reported to activate the transcription of SLC1A1 gene in prostate cancer condition, which leads to an increased expression of the drug transporter Excitatory amino acid transporter 3. | |||||
TF Superclass7: beta-Hairpin exposed by an alpha/beta-scaffold |
||||||
Class7.1: SMAD/NF-1 DNA-binding domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
SMAD3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC1A1 gene in hESCs condition | [17] | ||||
TF Protein Name |
Mothers against decapentaplegic homolog 3 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Mothers against decapentaplegic homolog 3 (SMAD3) has been reported to activate the transcription of SLC1A1 gene in human embryonic stem cells (hESCs) condition, which leads to an increased expression of the drug transporter Excitatory amino acid transporter 3. | |||||
SMAD4 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC1A1 gene in epithelial ovarian cancer condition | [18] | ||||
TF Protein Name |
Mothers against decapentaplegic homolog 4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Mothers against decapentaplegic homolog 4 (SMAD4) has been reported to activate the transcription of SLC1A1 gene in epithelial ovarian cancer condition, which leads to an increased expression of the drug transporter Excitatory amino acid transporter 3. | |||||
Transcriptional Phenomenon2 |
Activation of SLC1A1 gene in hESCs condition | [17] | ||||
TF Protein Name |
Mothers against decapentaplegic homolog 4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Mothers against decapentaplegic homolog 4 (SMAD4) has been reported to activate the transcription of SLC1A1 gene in human embryonic stem cells (hESCs) condition, which leads to an increased expression of the drug transporter Excitatory amino acid transporter 3. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.